查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1541385

2024-2032 年按产品、技术、应用和地区分類的表观遗传学市场报告

Epigenetics Market Report by Product, Technology, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球表观遗传学市场规模达24亿美元。

表观遗传学是指研究活性和非活性基因表现的遗传变化。变化的来源既可以是外在环境因素，也可以是内在因素，例如年龄和疾病。它通常用于诊断潜在疾病并防止其遗传给后代。它涉及使用各种酵素、仪器（例如测序仪、光谱仪和超音波仪）、试剂和套件。它们通常用于去氧核糖核酸 (DNA) 和组蛋白甲基化、非编码核糖核酸 (RNA)、乙酰化和磷酸化。因此，表观遗传学被广泛用于肿瘤、自体免疫、代谢、心血管和疼痛疾病的诊断、监测和治疗。

表观遗传学市场趋势：

全球癌症和自体免疫缺陷症候群（爱滋病）盛行率的不断上升是推动市场成长的关键因素之一。此外，针对非肿瘤疾病的表观遗传学解决方案的广泛采用正在推动市场成长。冠状病毒病（COVID-19）的突然爆发也为市场参与者提供了成长机会。例如，各研究机构正在进行先进的表观遗传学测试，以研究病毒对人类基因组的影响，并正在开发用于早期识别、风险评估和开发个人化治疗的工具。此外，DNA 和 RNA 修饰酶（如乙酰酶、甲基转移酶、逆转录酶和连接酶）的开发，以及高灵敏度和选择性测试和仪器的推出，也成为其他生长诱导因素。这些创新有助于评估基因组上位点特异性 DNA 甲基化。其他因素，包括生物技术领域广泛的研发（R＆D）活动，以及医疗保健基础设施的显着改善，尤其是在发展中经济体，预计将推动市场成长。

本报告回答的关键问题

  • 全球表观遗传学市场有多大？ 2024-2032年全球表观遗传学市场的预期成长率是多少？
  • 推动全球表观遗传学市场的关键因素是什么？
  • COVID-19 对全球表观遗传学市场有何影响？
  • 基于该产品的全球表观遗传学市场的细分情况如何？
  • 基于该技术的全球表观遗传学市场的细分情况如何？
  • 基于应用的全球表观遗传学市场的细分情况如何？
  • 全球表观遗传学市场的关键区域有哪些？
  • 全球表观遗传学市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球表观遗传学市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：依产品

  • 试剂
    • 市场趋势
    • 市场预测
  • 套件
    • 市场趋势
    • 关键环节
      • 晶片测序套件
      • 全基因组扩增试剂盒
      • 亚硫酸氢盐转换套件
      • RNA定序试剂盒
      • 其他的
    • 市场预测
  • 仪器仪表
    • 市场趋势
    • 市场预测
  • 酵素
    • 市场趋势
    • 市场预测
  • 服务
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依技术

  • DNA甲基化
    • 市场趋势
    • 市场预测
  • 组蛋白甲基化
    • 市场趋势
    • 市场预测
  • 组蛋白乙酰化
    • 市场趋势
    • 市场预测
  • 大非编码RNA
    • 市场趋势
    • 市场预测
  • 微小RNA修饰
    • 市场趋势
    • 市场预测
  • 染色质结构
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：按应用

  • 肿瘤学
    • 市场趋势
    • 关键环节
      • 实体肿瘤
      • 液体肿瘤
    • 市场预测
  • 非肿瘤学
    • 市场趋势
    • 关键环节
      • 发炎性疾病
      • 代谢性疾病
      • 传染病
      • 心血管疾病
      • 其他的
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abcam plc
    • Active Motif Inc.
    • Agilent Technologies Inc.
    • Diagenode Diagnostics (Hologic Inc)
    • Illumina Inc.
    • Merck KGaA
    • PerkinElmer Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
    • Zymo Research Corporation
Product Code: SR112024A4096

The global epigenetics market size reached US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.2 Billion by 2032, exhibiting a growth rate (CAGR) of 12.6% during 2024-2032.

Epigenetics refers to the study of heritable changes in the expression of active and inactive genes. The sources of changes can be both external from environmental factors or internal factors, such as age and disease. It is commonly used for the diagnosis of underlying conditions and preventing them from getting transferred to the future generations. It involves the use of various enzymes, instruments, such as sequencers, spectrometers and sonicators, reagents and kits. They are commonly utilized for deoxyribonucleic acid (DNA) and histone methylation, non-coding ribonucleic acid (RNA), acetylation and phosphorylation. As a result, epigenetics is widely used for the diagnosis, monitoring and treatment of oncological, autoimmune, metabolic, cardiovascular and pain disorders.

Epigenetics Market Trends:

The increasing prevalence of cancer and autoimmune deficiency syndrome (AIDS) across the globe is among the key factors driving the market growth. Moreover, the widespread adoption of epigenetic solutions for non-oncological ailments is providing a thrust to the market growth. The sudden outbreak of the coronavirus disease (COVID-19) is also providing growth opportunities to market players. For instance, various research institutes are running advanced epigenetic tests to study the impact of the virus on the human genome and are developing tools for early recognition, risk evaluations and developing personalized treatments. Additionally, the development of DNA and RNA modifying enzymes, such as acetylases, methyltransferases, reverse transcriptase and ligases, and the launch of highly sensitive and selective tests and instruments, are acting as other growth-inducing factors. These innovations facilitate the assessment of locus-specific DNA methylation on a genome. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global epigenetics market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product, technology, and application.

Breakup by Product:

Reagents

Kits

Chip Sequencing Kit

Whole Genomic Amplification Kit

Bisulfite Conversion Kit

RNA Sequencing Kit

Others

Instruments

Enzymes

Services

Breakup by Technology:

DNA Methylation

Histone Methylation

Histone Acetylation

Large Non-Coding RNA

MicroRNA Modification

Chromatin Structures

Breakup by Application:

Oncology

Solid Tumors

Liquid Tumors

Non-Oncology

Inflammatory Diseases

Metabolic Diseases

Infectious Diseases

Cardiovascular Diseases

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abcam plc, Active Motif Inc., Agilent Technologies Inc., Diagenode Diagnostics (Hologic Inc), Illumina Inc., Merck KGaA, PerkinElmer Inc., Roche Holding AG, Thermo Fisher Scientific Inc. and Zymo Research Corporation.

Key Questions Answered in This Report

  • 1. How big is the global epigenetics market?
  • 2. What is the expected growth rate of the global epigenetics market during 2024-2032?
  • 3. What are the key factors driving the global epigenetics market?
  • 4. What has been the impact of COVID-19 on the global epigenetics market?
  • 5. What is the breakup of the global epigenetics market based on the product?
  • 6. What is the breakup of the global epigenetics market based on the technology?
  • 7. What is the breakup of the global epigenetics market based on the application?
  • 8. What are the key regions in the global epigenetics market?
  • 9. Who are the key players/companies in the global epigenetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Epigenetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Kits
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Chip Sequencing Kit
      • 6.2.2.2 Whole Genomic Amplification Kit
      • 6.2.2.3 Bisulfite Conversion Kit
      • 6.2.2.4 RNA Sequencing Kit
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Instruments
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Enzymes
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Services
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 DNA Methylation
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Histone Methylation
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Histone Acetylation
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Large Non-Coding RNA
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 MicroRNA Modification
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Chromatin Structures
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Solid Tumors
      • 8.1.2.2 Liquid Tumors
    • 8.1.3 Market Forecast
  • 8.2 Non-Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Inflammatory Diseases
      • 8.2.2.2 Metabolic Diseases
      • 8.2.2.3 Infectious Diseases
      • 8.2.2.4 Cardiovascular Diseases
      • 8.2.2.5 Others
    • 8.2.3 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Active Motif Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Agilent Technologies Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Diagenode Diagnostics (Hologic Inc)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Illumina Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 PerkinElmer Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Roche Holding AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Thermo Fisher Scientific Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Zymo Research Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Epigenetics Market: Major Drivers and Challenges
  • Figure 2: Global: Epigenetics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Epigenetics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Epigenetics Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Epigenetics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Epigenetics Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Epigenetics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Epigenetics (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Epigenetics (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Epigenetics (Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Epigenetics (Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Epigenetics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Epigenetics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Epigenetics (Enzymes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Epigenetics (Enzymes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Epigenetics (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Epigenetics (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Epigenetics (DNA Methylation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Epigenetics (DNA Methylation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Epigenetics (Histone Methylation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Epigenetics (Histone Methylation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Epigenetics (Histone Acetylation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Epigenetics (Histone Acetylation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Epigenetics (Large Non-Coding RNA) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Epigenetics (Large Non-Coding RNA) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Epigenetics (MicroRNA Modification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Epigenetics (MicroRNA Modification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Epigenetics (Chromatin Structures) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Epigenetics (Chromatin Structures) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Epigenetics (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Epigenetics (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Epigenetics (Non-Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Epigenetics (Non-Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia-Pacific: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia-Pacific: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Epigenetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Epigenetics Market: Breakup by Country (in %), 2023
  • Figure 82: Middle East and Africa: Epigenetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Global: Epigenetics Industry: SWOT Analysis
  • Figure 84: Global: Epigenetics Industry: Value Chain Analysis
  • Figure 85: Global: Epigenetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Epigenetics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Epigenetics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Epigenetics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Epigenetics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Epigenetics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Epigenetics Market: Competitive Structure
  • Table 7: Global: Epigenetics Market: Key Players